Eton Pharmaceuticals, Inc.

ETON · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$4-$1-$9-$2
Dep. & Amort.$1$1$2$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$3$3$4$3
Change in WC-$1$4$8-$6
Other Non-Cash$1$0$0$0
Operating Cash Flow$1$7$5-$5
Investing Activities
PP&E Inv.-$0-$1-$0-$3
Net Acquisitions-$30$0$0$1
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$10$0-$3$0
Investing Cash Flow-$40-$1-$3-$3
Financing Activities
Debt Repay.$24-$1-$0-$0
Stock Issued$8$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$33-$1-$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$6$5$2-$7
Supplemental Information
Beg. Cash$21$16$14$21
End Cash$15$21$16$14
Free Cash Flow$1$6$2-$8
Eton Pharmaceuticals, Inc. (ETON) Financial Statements & Key Stats | AlphaPilot